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Abstract
Background: The aim of this study was to analyze the potential of proton magnetic resonance
spectroscopy (1H MRS) in diagnosing early inflammatory bowel disease (IBD).
Methods: Thirty male Sprague Dawley rats were fed 2% carrageenan in their diet for either 1 or
2 weeks. 1H MRS was performed ex-vivo on colonic mucosal samples (n = 123) and the spectra were
analyzed by a multivariate method of analysis. The results of the multivariate analysis were
correlated with histological analysis performed using H & E stain for the presence of inflammation
in the samples from each group.
Results: Multivariate analysis classified the samples in their respective groups with an accuracy of
82%. Our region selection algorithm identified four regions in the spectra as being discriminatory.
The metabolites assigned to these regions include creatine, phosphatidylcholine, the -CH2HC=
group in fatty acyl chain, and the glycerol backbone of lipids. The differences in concentration of
these metabolites in each group offer insight into the biochemical changes occurring during IBD
and confer diagnostic potential to 1H MRS as a tool to study colonic inflammation in conjunction
with biopsy.
Conclusion: 1H MRS is a sensitive tool to detect early colonic inflammation in an animal model of
IBD.
Background
Inflammatory Bowel Disease (IBD) is a common condi-
tion in North America with rising incidence in previously
less affected areas worldwide [1]. It is classified as ulcera-
tive colitis and Crohn's disease. IBD shows a bimodal
peak of appearance of the disease; typically, one in the
population aged 15–25 years and another peak later in
life around 60 years of age [2]. Recently, it has been shown
that the incidence of IBD is increasing in the pediatric
population [1]. It is known that ulcerative colitis is associ-
ated with an increased risk of colorectal cancer. The inci-
dence of colorectal cancer is estimated to be 2% in people
who have had ulcerative colitis for 10 years, approaches
8% after 20 years and 18% after 30 years of having the dis-
ease [3]. As such, people diagnosed with ulcerative colitis
at a younger age are exposed to a significant risk of devel-
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oping colorectal cancer. IBD has a multifactorial etiology
that includes an interplay of genetic, environmental and
immunological factors [2]. Diet is one of the major envi-
ronmental factors that is being postulated to be associated
with IBD and cancer.
Dietary fat may be one of the critical determinants of
pathogenesis and remission in IBD [4]. Polyunsaturated
fatty acids (PUFA), specifically omega-3 fatty acids, are
currently being explored for therapeutic assistance for
colon cancer. Studies analyzing this effect in IBD and its
transition to colon cancer are however, very limited.
Recently, Meister, et al. showed that in vitro treatment of
colon biopsies from IBD patients with omega-3 fatty acid
reduced inflammation [5]. In a crossover study by Aslan et
al., IBD patients on omega-3 supplements showed clinical
improvement, and in 72% of them it was possible to stop
or reduce the medication. However, no histopathological
or biochemical improvement was observed in the patients
[6]. The studies so far are controversial and have pointed
towards the fact that there are many critical limitations in
conducting human studies on dietary influence in IBD.
Since some of these patients may be on medical therapy,
having a pure placebo-control group will be very difficult.
Moreover, taking frequent biopsies in these patients may
not be possible.
To overcome such design limitations in studies meant to
evaluate the effect of diets in the window between IBD
and colon cancer, the use of an animal model that closely
resembles human ulcerative colitis becomes imperative.
Many chemicals have been tried to induce experimental
colitis in animals [7]. Degraded lambda-carrageenan has
been shown to cause inflammation similar to human IBD
in a rodent model [8]. In a preliminary study (unpub-
lished observation), our lab has shown that carrageenan
can cause colitis without massive ulceration and may be
suitable for long term studies on IBD as also suggested by
others [9]. Based on these observations, we have used
Sprague-Dawley rats fed with 2% degraded carrageenan as
our model for IBD.
Another factor in conducting studies on IBD is the availa-
bility of a sensitive tool to assess inflammation. Currently,
histopathological analysis is the gold standard for evalu-
ating inflammation. As biochemical and molecular
changes are known to precede histological manifestation
of a disease, assessing biochemical changes would provide
an opportunity to diagnose IBD at an early stage, allowing
timely intervention. Magnetic resonance spectroscopy
(MRS) is a technique that is extensively used to character-
ize the metabolic profiles of tissues both in vivo and ex
vivo [10,11]. 1H MRS is a robust and widely used tech-
nique that identifies proton signals from various biologi-
cal samples [12,13]. As proton-containing metabolites are
very prevalent in tissues, 1H MRS is well equipped to
detect the presence and relative change in concentration
of these metabolites. 1H MR spectra show a complex array
of metabolites present in the tissue, which can make the
interpretation very difficult. To overcome this problem, a
computer-based multivariate analysis method is being
used. Multivariate analysis is particularly useful when the
spectra from different experimental groups show only
subtle differences in the intensity of metabolite peaks
[14]. Together with 1H MRS, it constitutes the critical tech-
nique used in the rapidly expanding field of 'metabonom-
ics' [15]. Bezabeh et al. have previously shown that 1H
MRS has a potential to detect early inflammation, and
also to differentiate between ulcerative colitis and Crohn's
disease [10].
Methods
Experimental design and sample collection
Thirty male Sprague-Dawley rats (Charles River, Canada)
were divided into three groups of 10 animals each. The
animals in the control group were fed a regular American
Institute of Nutrition-76A (AIN-76A) diet for 2 weeks;
animals in the 1 week treated group were fed a regular diet
for 1 week followed by 2% carrageenan (Sigma, St. Louis,
MO, USA) by weight for another 1 week; animals in the 2
weeks treated group received 2% carrageenan by weight
with their diet for 2 weeks. The diets were made in-house
and the ingredients were purchased from Harlan Teklad,
Toronto, Ontario, Canada. All the animals were sacrificed
at the end of the 2nd week by carbon dioxide asphyxiation.
After sacrificing the animals, the colon was excised and
the mucosal layer scraped off using a glass slide as
described by Briere, et al. [16]. The mucosal specimens
were stored in Phosphate Buffered Saline mixed with deu-
terium oxide (PBS/D2O) in cryovials and kept frozen at -
80°C until processed. All the animal work was conducted
at the University of Waterloo. The animal care and han-
dling procedures were done in accordance with the Ani-
mal Ethics guidelines at the University of Waterloo and
the National Research Council of Canada, Winnipeg. The
mucosal specimens were coded and then shipped on dry
ice to the Institute for Biodiagnostics, National Research
Council of Canada, Winnipeg for 1H MRS and histologi-
cal assessment.
1H MRS experiments
Each specimen was thawed and cut into 5–7 mm long
pieces, which yielded on average 18–20 pieces. 1H MRS
was conducted on alternate pieces, resulting in a total of
123 spectra. The samples were positioned in glass capil-
lary tubes for 1H MRS experiments as described by Kuesel,
et al. [17]. Briefly, the colon sample was placed in a glass
capillary tube filled with PBS/D2O with one end plugged.
This capillary was inserted into the NMR tube containing
300 µl of PBS/D2O solution and 5 µl of chemical shift ref-Journal of Inflammation 2007, 4:24 http://www.journal-inflammation.com/content/4/1/24
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erence, 3-Trimethylsilyl-Propionic acid-D4- sodium salt
(TSP). 1H MRS was conducted on these samples using a
Bruker Avance 360 MHz spectrometer at 25°C with pre-
saturation of the water signal. The acquisition parameters
included: 90° pulse at 9.30 µsec, number of scans = 256,
spectral width = 4990.02 Hz, relaxation delay = 3 sec and
time domain data points = 8 K. The samples were fixed in
10% neutral buffered formalin immediately after 1H MRS
experiments for histological assessment.
MRS data analysis
For multivariate analysis, each MRS spectrum was normal-
ized by dividing the data points by the total spectral area
and then aligned to the reference peak due to TSP. The
region between 0.5 and 4.5 ppm was selected to eliminate
the excess water signal at 4.7 ppm. First derivatives were
taken, and rank ordering was done on the resulting data
to eliminate baseline differences between the spectra. For
control vs each of the treatment groups, random subsets
of the data were used to train a genetic algorithm-based
subregion selection method [18]. A histogram was con-
structed and the regions that stood out as being selected
most often were used to develop the final classifier: linear
discriminant analysis (LDA) with coefficients optimized
using a bootstrapping method [19].
Histological analysis
The formalin fixed samples were embedded in paraffin
blocks and cut into 5 µm sections. The sections were
stained with Hematoxylin and Eosin (H&E) stains. The
slides were analyzed under a Nikon inverted microscope
at 40× resolution and pictures were taken using a Nikon
CoolPix 5000 digital camera. Before making paraffin
blocks, the samples were coded to eliminate measurement
bias. The samples were decoded only after recording the
findings of histological analysis.
Blood analysis
Blood samples were sent to the laboratory services divi-
sion at the University of Guelph for complete and differ-
ential cell count. Carrageenan has been shown to induce
systemic response [8], hence we speculated an increase in
the white cell count in the blood of treated animals.
Results
Multivariate analysis was performed to compare the spec-
tra from the control group with both treatment groups.
Multivariate analysis showed a significant overlap
between the spectral data of the 1-week treated group and
both the control and the 2-week treated groups. This indi-
cates that after a period of 1 week, there is some inflam-
mation in the colon, but not significant enough to set it
apart from the normal colon. The analysis of the control
and 2-week treated groups yielded results as shown in
Table 1. All of the spectra (n = 123) were included in this
analysis without correlating the data with histology.
After conducting multivariate analysis on the complete
dataset, histological assessment was performed. Figure 1
shows representative spectra from the control group and
the 2 week-treated group along with the corresponding H
& E stained images from the same specimens. In the his-
tological assessment, it was observed that some samples
had significant contamination by muscle tissue from the
deeper layers of the colonic wall. These samples (n = 10)
were eliminated from the analysis. The remaining 113
samples were evaluated for the degree of inflammation.
The histological analysis of these samples revealed that
some of the samples from the control group were actually
inflamed and some samples from the 2-week treated
group did not show any signs of inflammation. Also, it
was noticed that there were differences in some of the
spectral features from individual samples within the same
group. This is possibly due to the fact that some of these
animals did not develop any significant inflammation. In
addition, the inflammation can also be patchy and may
not be present uniformly throughout the colon [20].
However, we could not give a plausible explanation for
colonic inflammation observed in the control group. Such
spectra (n = 29) were removed from the full dataset (Table
1) and analyzed separately. Henceforth, these spectra will
be referred to as 'aberrant spectra'.
After correlating with histology, the remaining 113 spectra
were subjected to multivariate analysis. It was necessary to
train the classifier on 'pure' spectra (n = 84) so as to dis-
tinctly identify the characteristics of inflamed and non-
inflamed samples. Therefore, the aberrant spectra from
Table 1: Multivariate analysis results of all MR spectra without histological confirmation (n = 123)
Control Vs. 2 weeks Carrageenan-treated group
Desired Class N Classification Accuracy Overall Accuracy
Correct False
Control 63 50 13 79.4% 77.2%
Treated 60 45 15 75.0%Journal of Inflammation 2007, 4:24 http://www.journal-inflammation.com/content/4/1/24
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Representative 1H MR spectra (360 MHz) and the histology sections from the control group and 2 week-treated group Figure 1
Representative 1H MR spectra (360 MHz) and the histology sections from the control group and 2 week-treated group; (i) MR 
spectrum of specimen from control group (ii) MR spectrum of specimen from 2 week-treated group (iii) H&E stained section 
of the same control group specimen as above (iv) H&E stained section of the same specimen from 2 week-treated group as 
above. The metabolites represented by the labeled peaks in the MR spectra are as follows: (a) -CH3 group of fatty acids in lip-
ids, (b) -CH2 chain of fatty acids, (c) glutamic acid, d) -CH2-COO group of fatty acids, (e) polyunsaturated fatty acids, (f) creat-
ine, (g) total cholines (tCho), (h)-CH2-CH= group of unsaturated fatty acids.
Table 2: Results of multivariate analysis with histological confirmation (n = 84)
Control Vs. 2 weeks Carrageenan-treated group
Desired Class N Classification Accuracy Overall Accuracy
Correct False
Control 38 31 7 81.6% 82.1%
Treated 46 38 8 82.6%Journal of Inflammation 2007, 4:24 http://www.journal-inflammation.com/content/4/1/24
Page 5 of 7
(page number not for citation purposes)
both control and 2 weeks treated group (n = 29) were not
used to develop the classifier for the multivariate analysis.
Table 2 shows the results of the multivariate analysis of
the main dataset (n = 84). The accuracy with which these
samples were assigned to their respective groups increased
from 77.2%, in the initial analysis, to 82%.
The aberrant dataset (n = 29) was separately submitted to
the classifier developed using the 'pure' spectra. Out of the
16 'control' samples found to be inflamed on histological
assessment, the multivariate analysis classified 10 as '2
weeks treated', i.e. inflamed. Similarly, out of the 13 car-
rageenan-treated samples that were found to be inflam-
mation-free on histological assessment, the multivariate
analysis classified 9 as 'control'.
The reason why the four "control" samples were classified
as "inflamed" by our analysis remains unclear. Further
investigation needs to be undertaken on such samples to
understand the exact reason for the misclassification.
One of the reasons for not attaining 100% accuracy in the
MRS analysis may be the intragroup variation, particularly
in the carrageenan-treated group. The degree of inflamma-
tion widely varied within the same group. Differences in
intensities of metabolite peaks were observed among indi-
vidual spectra from the same group of animals and in fact,
from the same animal. The averaging of these variations in
spectral intensities may have resulted in blunting of the
effect of certain metabolites during multivariate analysis.
This problem can be overcome by using a larger sample
size to reduce the effect of individual variations.
Other factors that may raise concerns about the variability
in the results include the use of CO2 asphyxiation method
to euthanize the animals, leading to acute cell injury and
mechanical injury during sample preparation. We felt that
since we were using the same method of euthanization for
all groups, this variable was common to both groups. In
addition, acute hypoxic events need some time to be
translated as biochemical change in the colon. The initial
response to CO2 asphyxiation is respiratory acidosis and
the brunt is on organs that are metabolically more active
like brain and heart. There may also have been some tis-
sue trauma and alteration in metabolic profile during
stripping of colonic mucosa from the deeper layers. Every
effort was made to minimize trauma during sample col-
lection procedure. This procedure was performed by one
person in an effort to keep the processing time and force
reasonably uniform for all the samples.
Our region selection algorithm identified 4 regions of the
spectra that were most discriminatory, i.e. were selected
most often by the genetic algorithm. These included spec-
tral resonances due to the -CH2HC= group in fatty acyl
chain of triglycerides (2.79–2.83 ppm), creatine (3.00
ppm), phosphocholine (3.56–3.60 ppm) and glycerol
backbone of lipids (4.03–4.05 ppm).
Discussion and conclusion
Martin et al. have characterized the metabolic profile of
rodent intestinal tissue including proximal and distal
colon using high resolution 1H MRS [21]. They observed
significant levels of phosphatidylcholine, creatine, glyc-
erol and triglycerides in the normal colon. Phosphatidyl-
choline is the predominant phospholipid present in the
cell membranes [22] including colonic mucosal cells [23].
It is also an important constituent of the inflammatory
mediator, platelet activating factor (PAF). PAF is crucial
for critical steps in inflammatory cascade such as platelet
activation and increase in vascular permeability. The
active species of PAF have been shown to increase signifi-
cantly in mucosal biopsies from ulcerative colitis patients
[24]. PAF levels in stool are considered diagnostic and
indicative of severity in patients with ulcerative colitis
[25]. The increased levels of phosphatidylcholine seen in
our study may be because of increased levels of PAF in col-
itis. Increased apoptosis and cell turnover in IBD may also
contribute to increased phosphatidylcholine concentra-
tion in colonic mucosa.
Creatine is a metabolite present in normal tissues and
serves as an energy reservoir. It is converted via a reversible
reaction into phosphocreatine by adding a high energy
phosphate bond in the presence of creatine kinase. Phos-
phocreatine is broken down to creatine while releasing
energy as ATP whenever required. Significant concentra-
tions of creatine have previously been detected in human
colonic mucosa [26]. The BB isoenzyme of creatine kinase
has been isolated from normal [27] and infracted colonic
mucosa [28]. As colonic inflammation causes cellular
damage and increased requirement for energy, the creat-
ine concentrations may be elevated in these cells.
The region around 2.8 ppm denotes the peak from pro-
tons in polyunsaturated fatty acids (PUFA) [29]. PUFAs
are critical for maintaining the membrane structure and
function of various cells in the body [30]. Linoleic acid is
an important constituent of the lipid bilayer of cell mem-
branes and a precursor for another PUFA, arachidonic
acid. Arachidonic acid, in turn, is the precursor of potent
inflammatory mediators such as LT-B4 and PG-G2.
These inflammatory markers are increased in many disor-
ders in the human body including IBD [31]. Nishida et al.,
observed an increase in arachidonic acid concentration in
the mucosa of patients with ulcerative colitis [32]. Nieto
et al. also observed an increase in linoleic acid concentra-
tion in the colonic mucosa of rats 2 weeks after inducing
experimental colitis [33]. Increase in glycerol resonance inJournal of Inflammation 2007, 4:24 http://www.journal-inflammation.com/content/4/1/24
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our samples may be reflective of an increase in the total
lipids in the colonic mucosa during inflammation. These
changes in colonic mucosal lipid profile are similar in
human ulcerative colitis as well as experimental colitis in
animals.
It should be noted that the above metabolites are seen in
normal as well as diseased states in colonic mucosa. The
difference in their intensities is what is more significant
and indicative of a disease process as opposed to only the
presence or absence of these metabolites. The change in
the overall profile of the spectrum, and not changes in the
intensity of only one or two specific peaks, is a better indi-
cator of the disease process.
To assess the systemic effects of colonic inflammation, we
analyzed blood samples from animals in the control (n =
5) and 2 week-treated group (n = 6). As IBD is a chronic
inflammation, we compared the lymphocyte counts in
these animals. In 10 out of these 11 animals, the histolog-
ical assessment of inflammation agreed with their respec-
tive lymphocyte counts. In one animal, the samples were
classified as inflamed by histology whereas the lym-
phocyte counts were not raised. Since the samples from
this animal were kept in the refrigerator for longer period
of time than any other sample (over 2 days), some
changes might have occurred in the tissue specimens
interfering with the results of the histological analysis.
The results of this study need to be further reinforced by
correlating the findings of 1H MRS with systemic markers
of inflammation such as leukotriene B4 levels, serum C-
reactive protein, albumin and thrombocytosis. In addi-
tion, testing the reproducibility of these results in other
models of colonic inflammation such as IL-10 knock-out
mice and dextran sulphate-induced colitis model will
help validate this new role of 1H MRS. Moreover, there
may be critical differences in the degree and chronicity of
inflammation in different parts of the colon. Based on the
results of this study, further work needs to be undertaken
to examine the differences in inflammatory profile
between distal, middle and proximal colon.
In conclusion, this study demonstrates that 1H MRS com-
bined with multivariate analysis is a highly sensitive tech-
nique to distinguish between inflamed and non-inflamed
colonic tissue. In addition, it also suggests that 1H MRS
can serve as a tool to study the sequential progression of
IBD and explore the effect of various dietary and therapeu-
tic agents on this process. This model will be helpful to
approach a multitude of questions like whether and how
dietary practices can affect the development and progres-
sion of IBD. It will also enable us to overcome some of the
limitations faced in human studies.
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